Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120,538,577
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
7,316,794
-
Shares change
-
-415,515
-
Total reported value, excl. options
-
$6,939,218
-
Value change
-
-$2,147,972
-
Put/Call ratio
-
6.6%
-
Number of buys
-
28
-
Number of sells
-
20
-
Price
-
$0.9538
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) as of Q1 2025
As of 31 Mar 2025 REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,316,794 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, DIADEMA PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Schonfeld Strategic Advisors LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, MARSHALL WACE, LLP, and Private Advisor Group, LLC.
This table shows 69 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.